News
Industry Leaders Join Forces to Discuss Optimizing eConsent for Patient Centricity
Informative webinar hosted by CRF Health, a CRF Bracket company, will address how eConsent can be implemented effectively to support patient centricity and improve...
Press Releases
New Digital Marketplace for Life Science Products – Built with Scientists in Mind
Labviva, an AI-powered digital marketplace for life science reagents, instrumentation and services announces its launch to create scientifically informed purchasing decisions. ...
Research Insight
Eisai and UCLommence preparations for phase i clinical studies in Alzheimer’s Disease for Novel Anti-Tau Antibody
Eisai Co., Ltd and University College London announced that they have commenced preparations for Phase I clinical studies on E2814 The...
Press Releases
AstraZeneca and Cancer Research UK launch Functional Genomics Centre to accelerate the discovery of new medicines
AstraZeneca announced a new collaboration with Cancer Research UK to launch a centre of excellence in genetic screening, cancer modelling and big data processing...
Clinical Trials
Phase 3 Trial of Rova T as Second-line Therapy for Advanced Small-Cell Lung Cancer Halted
AbbVie , a research-based global biopharmaceutical company, announced the decision to stop enrollment for the TAHOE trial, a Phase 3 study evaluating Rovalpituzumab Tesirine...
News
Pharma torch bearers congregate to select industry’s best in class in Mumbai
The India Pharma Awards, conducted by UBM India, India’s leading B2B exhibitions organizer, concluded the second and final round of jury selection at The...
Press Releases
Recipharm’s proprietary molecule Erdosteine recognised as COPD treatment
Recipharm has announced that its proprietary molecule Erdosteine has been officially recognised by the GOLD (Global Initiative for Chronic Obstructive Lung disease) Scientific Committee...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
















